Lillian Smith
Compliance Officer bei ALLOGENE THERAPEUTICS, INC.
Vermögen: 400 813 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Lillian Smith
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lillian Smith
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Private Equity Investor Chief Tech/Sci/R&D Officer | |
Biomet, Inc.
 Biomet, Inc. Medical SpecialtiesHealth Technology Biomet, Inc. engages in the design, manufacture, and market of musculoskeletal therapy products. The company was founded by Dane A. Miller, Niles L. Noblitt, Jerry L. Ferguson and M. Ray Harroff on November 30, 1977 and is headquartered in Warsaw, IN. | Medical Specialties | Director/Board Member | |
| BIOLIFE SOLUTIONS, INC. | Medical Specialties | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CERUS CORPORATION | Medical Specialties | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
IASIS Healthcare LLC
 IASIS Healthcare LLC Medical/Nursing ServicesHealth Services IASIS Healthcare LLC owns and operates acute care hospitals. It operates business through two segments: Acute Care and Health Choice. The Acute Care segment comprises of its hospitals, outpatient service facilities and physician clinics which offers a variety of medical and surgical services commonly available in hospitals, including emergency services, general surgery, internal medicine, cardiology, obstetrics, orthopaedics, psychiatry and physical rehabilitation. The Health Choice segment is a provider-owned, managed care organization and insurer. The company was founded in 1998 and is headquartered in Dallas, TX. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
WISeKey SA
 WISeKey SA Information Technology ServicesTechnology Services WISeKey SA develops and provides encryption and security system products. Its e-government knowledge centre offers information and services on the programs and projects in the areas of e-voting, national identity systems, electronic identification, e-passports, e-procurement, e-health and other e-government related projects. The company was founded by Carlos Creus Moreira in 1999 and is headquartered in Geneva, Switzerland. | Information Technology Services | Director/Board Member | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Chairman Consultant / Advisor Private Equity Investor | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor President | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
Forstmann Little & Co.
 Forstmann Little & Co. Investment ManagersFinance Forstmann Little & Co. (Forstmann Little) is an independent private equity firm founded in 1978. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
BIAL-Portela & Cia SA
 BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | Pharmaceuticals: Major | Director/Board Member | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Chief Executive Officer | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Founder Founder | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Biotechnology | Director/Board Member | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chairman | |
Emil Frey Holding AG
 Emil Frey Holding AG Specialty StoresRetail Trade Emil Frey Holding AG imports and distributes vehicles. The company was founded on November 9, 1970 and is headquartered in Zurich, Switzerland. | Specialty Stores | Director/Board Member | |
| Emil Frey SA Genève | Director/Board Member | ||
| KITE PHARMA INC | Biotechnology | Director/Board Member Founder Chief Executive Officer Director/Board Member Investor Relations Contact Chief Tech/Sci/R&D Officer Director/Board Member Private Equity Investor Chief Tech/Sci/R&D Officer | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Tarrant Capital IP LLC
 Tarrant Capital IP LLC Investment ManagersFinance Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA. | Investment Managers | Founder President Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Consultant / Advisor Chief Executive Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
Wisekey USA, Inc.
 Wisekey USA, Inc. Information Technology ServicesTechnology Services Part of WISeKey International Holding Ltd., Wisekey USA, Inc. develops and provides encryption and security systems products. The company is based in Syracuse, NY. The CEO of the company is Joao Carlos Creus Moreira. | Information Technology Services | Director/Board Member | |
| WISEKEY INTERNATIONAL HOLDING AG | Semiconductors | Director/Board Member | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Founder Consultant / Advisor Consultant / Advisor | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | President | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Consultant / Advisor Founder | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Fusionkite | Director/Board Member | ||
| INSTIL BIO, INC. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Chairman | |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman | |
| Breakthrough Services LLC | Director/Board Member Chairman | ||
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Chairman | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| TPG INC. | Investment Managers | Founder President Director/Board Member | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 40 |
| Schweiz | 7 |
| Hong Kong | 2 |
| Japan | 2 |
| Portugal | 2 |
Sektoral
| Health Technology | 23 |
| Finance | 15 |
| Consumer Services | 5 |
| Technology Services | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 233 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 63 |
| Chairman | 44 |
| Founder | 37 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Bonderman | 89 |
| Franz Humer | 45 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Todd Sisitsky | 37 |
| Vicki Sato | 28 |
| Owen Witte | 17 |
| David Chang | 16 |
| Geoffrey Parker | 16 |
| Timothy Moore | 15 |
| Elizabeth Barrett | 14 |
| Stephen Mayo | 12 |
| Deborah Messemer | 12 |
| Christine Cassiano | 11 |
| Earl Douglas | 9 |
- Börse
- Insiders
- Lillian Smith
- Unternehmensverbindungen
